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A Drive-thru Anticoagulation Testing Clinic during COVID-19 Pandemic 
 
By: Tina Hyman, MSN, RN-BC; Nohemi Sadule-Rios, PhD, APRN; Robert P. Ramirez, BSN, RN-BC  
ABSTRACT 
As COVID-19 started to spread rapidly in their community, a team of nurses at South Miami Hospital 
initiated a drive-thru anticoagulation testing process to provide safe access to care for patients on anti-
coagulation therapy, requiring Internationalized Ratio (INR) testing. This article describes the imple-
mentation of a drive-thru anticoagulation testing process and implications for best practices during a 
pandemic crisis.  
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BACKGROUND 
 COVID-19 has significantly changed 
healthcare delivery. As the novel coronavirus, 
SARS-CoV-2, started to spread rapidly around 
the world, scientists tried to understand the trans-
missibility of this virus and governments began 
to implement measures to slow down the pan-
demic. A study on the first known person-to-
person transmission of severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2) in the 
United States of America revealed that extended, 
unprotected exposure led to COVID-19 trans-
mission from one individual to another (Ghinai 
et al., 2020). Another study indicated that trans-
missions occurred in community settings (Pung 
et al., 2020). More evidence suggested the trans-
missibility of the virus by asymptomatic and pre-
asymptomatic carriers (Huff & Singh, 2020). 
 Following the Centers for Disease Control 
(CDC) and states’ recommendations, healthcare 
systems in the United States implemented rigor-
ous measures to protect human lives and prevent 
the transmission of COVID-19. Some of the 
safety measures implemented immediately by 
the Anticoagulation Clinic included restricting 
visitors, social distancing, mandating face cover-
ing, and ensuring employees’ appropriate use of 
personal protective equipment (PPE).  
 
FACING THE CHALLENGE 
 The Anticoagulation Clinic opened in 2007, 
and grew quickly, exceeding 500 patient visits 
monthly. The clinic improved patient outcomes, 
reduced warfarin-related adverse drug reactions 
(ADRs), and warfarin-related hospital readmis-
sions by 71%. However, once SARS-CoV-2  
Figure 1 
Anticoagulation clinic team 
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invaded the lives of Americans, the clinic’s pa-
tient care process was no longer effective. The 
census dropped acutely from the once normal 25 
– 30 patient visits to 10 patient visits daily, as the 
pandemic spread into Miami-Dade County. Con-
sequently, a team of nurses caring for these pa-
tients, consisting of a nurse manager, an office 
supervisor, two advanced practice registered 
nurses (APRN), four registered nurses (RN), a 
clinical educator, and four clerical staff members 
became increasingly concerned for their long-
term patients needing INR testing for safe antico-
agulation therapy (Figure 1). According to The 
Joint Commission National Patient Safety Goal 
NPSG.03.03.01, EP 1, anticoagulation medica-
tions have a higher risk for causing harm to pa-
tients due to the complex dosing, insufficient 
monitoring, and poor patient compliance making 
the clinic’s efforts to keep their patients safe vi-
tally important  (The Joint Commission, 2018).  
 
NURSES INGENUITY TO CARE FOR             
PATIENTS 
 The clinic’s team rallied to ensure patients 
were and felt safe despite the great stress and 
fear that the COVID-19 had brought. Along with 
the reports that drive-thru COVID-19 testing had 
become available in other parts of the country, 
the clinic’s educator suggested a drive-thru test-
ing process for the Anticoagulation Clinic      
patients. As soon as the team received approval 
by key administrators, a new process arose from 
the pandemic crisis. 
 With the new process, patients do not need 
to come into the hospital clinic to receive testing 
and care (Figure 2). The day before appoint-
ments, nurses make reminder calls as usual, with 
additional dialogue that included new COVID-19 
screening questions, location of the drive-thru 
site, requirement of wearing facial covering/
mask, and instructions to lower only the patient’s 
window to prevent airborne exposure from a 
draft during the appointment. Upon arrival, the 
patient’s temperature is checked, registration 
process is completed, two required patient identi-
fiers are confirmed with the patient, and the point 
of care equipment is prepared. The nurses wear 
CDC recommended PPE during any transactions 
with the patients. Additionally, nurses provide 
diet recommendations, medication education, 
and address patients’ concerns as the capillary 
sample is collected. Using the point of care 
equipment, the INR result along with any       
pertinent information is then reported via phone 
to one of the two registered nurses (RNs) seated 
inside the clinic. The receiving RNs already have 
the patient’s account and visit history available 
on their computer monitors. They determine 
whether medication dosing changes are neces-
sary, seek feedback from the APRN, reconcile 
the home medication list, document any infor-
mation received on the patient through report, 
and schedule the next visit.  
 The drive-thru anticoagulation testing pro-
cess provides patients with both a convenient and 
safe testing environment to alleviate the fear of 
entering the hospital as well as a sense of nor-
malcy that comes with seeing the familiar nurs-
es’ faces and receiving the professional care to 
which they are accustomed. This sentiment has 
been echoed by the resounding “thank-you”   
appreciations received from the patients who 
have trusted the RNs’ guidance with their thera-
Figure 2 
Anticoagulation clinic new testing process 
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py prior to and now, during this COVID-19 pan-
demic crisis. 
 
IMPACT OF THE DRIVE-THROUGH ANTI
-COAGULATION CLINIC 
 Results from a recent patient satisfaction sur-
vey administered to the clinic patients indicated 
that most of the surveyed patients (61%) would 
not have come to their regular clinic visit inside 
the hospital and that they had no intention of get-
ting checked anywhere else until after the pan-
demic had passed. All surveyed patients gave the 
drive-through clinic new testing process the high-
est satisfaction score. Clinic patients were also 
satisfied with the drive-thru turnaround time, 
which is considerably less than the traditional 
process. A routine visit that used to take between 
30 to 45 minutes to park, register, wait, and be 
seen now takes, on average, less than of < 15 
minutes.  
 
CONCLUSION AND IMPLICATIONS FOR 
PRACTICE 
 The drive-thru anticoagulation testing pro-
cess was created to provide safe and effective 
care for patients taking warfarin. Since social 
distancing is one of the most essential strategies 
to prevent transmission of the virus (Qian & 
Jiang, 2020), driving-thru instead of coming into 
the clinic, helped our patients feel safe and at 
ease. Moreover, the use of masks provides effec-
tive protection against the virus (Lianga et al., 
2020). The team knew that their patients’ lives 
were at risk if they were not being managed ap-
propriately during the COVID-19 pandemic.  By 
implementing an innovative drive-through pro-
cess to facilitate INR testing, the patient experi-
ence has improved, and the number of cancella-
tions has decreased. Furthermore, the clinic staff 
continues to work with minimum adjustments to 
their daily routine. 
 This initiative exemplifies the values, mis-
sion, and vision of this healthcare system and of 
the leaders who uphold and prioritize the lives of 
the patients and community served every day, 
even during the chaos caused by a global pan-
demic.  
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